Username


Password

Preview

David Kendall

Publications

  • TOP 3
  • Maha M Elbatsh; N Assareh; C A Marsden; D A Kendall
    Anxiogenic-like effects of chronic cannabidiol administration in rats.
  • Saoirse E O'Sullivan; Patrick J Kendall; David A Kendall
    Endocannabinoids and the cardiovascular response to stress.
  • Sarir Sarmad; Stephen P H Alexander; David A Barrett; Charles A Marsden; David A Kendall
    Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices.
Register to see all publications

Register for free to view:

Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the research activity
of experts around the globe
Register to see more

Geonetwork of David Kendall (preview)

  • Cities where this author has publications
  • Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

  • 2012: Maha M Elbatsh; N Assareh; C A Marsden; D A Kendall
    Anxiogenic-like effects of chronic cannabidiol administration in rats.
    Psychopharmacology 2012;221(2):239-47.
  • 2012: Saoirse E O'Sullivan; Patrick J Kendall; David A Kendall
    Endocannabinoids and the cardiovascular response to stress.
    Journal of psychopharmacology (Oxford, England) 2012;26(1):71-82.
  • 2011: Sarir Sarmad; Stephen P H Alexander; David A Barrett; Charles A Marsden; David A Kendall
    Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices.
    Journal of neurochemistry 2011;117(4):665-77.
  • 2011: G A Scullion; D A Kendall; C A Marsden; D Sunter; M-C Pardon
    Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
    Neuropharmacology 2011;60(2-3):223-34.
  • 2011: Devi Rani Sagar; James J Burston; Gareth J Hathway; Stephen G Woodhams; Richard G Pearson; Andrew J Bennett; David A Kendall; Brigitte E Scammell; Victoria Chapman
    The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain.
    Molecular pain 2011;7():88.
  • 2010: Devi Rani Sagar; Lydia E Staniaszek; Bright N Okine; Stephen Woodhams; Leonie M Norris; Richard G Pearson; Michael J Garle; Stephen P H Alexander; Andrew J Bennett; David A Barrett; et al.
    Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.
    Arthritis and rheumatism 2010;62(12):3666-76.
  • 2010: S E O'Sullivan; D A Kendall
    Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
    Immunobiology 2010;215(8):611-6.
  • 2010: L E Staniaszek; L M Norris; D A Kendall; D A Barrett; V Chapman
    Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids.
    British journal of pharmacology 2010;160(3):669-76.
  • 2010: Devi Rani Sagar; Maulik D Jhaveri; Denise Richardson; Roy A Gray; Eva de Lago; Javier Fernández-Ruiz; David A Barrett; David A Kendall; Victoria Chapman
    Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
    The European journal of neuroscience 2010;31(8):1414-22.
  • 2010: Ivan Rattray; Alain Pitiot; James Lowe; Dorothee P Auer; Sarah-Jane Lima; Mirjam I Schubert; Malcolm J W Prior; Charles A Marsden; Fernando Pérez Diaz; David A Kendall; et al.
    Novel cage stress alters remote contextual fear extinction and regional T2 magnetic resonance relaxation times in TASTPM mice overexpressing amyloid.
    Journal of Alzheimer's disease : JAD 2010;20(4):1049-68.
  • 2009: L Jean-Gilles; S Feng; C R Tench; V Chapman; D A Kendall; D A Barrett; C S Constantinescu
    Plasma endocannabinoid levels in multiple sclerosis.
    Journal of the neurological sciences 2009;287(1-2):212-5.
  • 2009: G A Scullion; D A Kendall; D Sunter; C A Marsden; M-C Pardon
    Central noradrenergic depletion by DSP-4 prevents stress-induced memory impairments in the object recognition task.
    Neuroscience 2009;164(2):415-23.
  • 2009: Marie-Christine Pardon; Sarir Sarmad; Ivan Rattray; Timothy E Bates; Gillian A Scullion; Charles A Marsden; David A Barrett; James Lowe; David A Kendall
    Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Neurobiology of aging 2009;30(7):1099-113.
  • 2009: Saoirse E O'Sullivan; Yan Sun; Andrew J Bennett; Michael D Randall; David A Kendall
    Time-dependent vascular actions of cannabidiol in the rat aorta.
    European journal of pharmacology 2009;612(1-3):61-8.
  • 2009: Ivan Rattray; Gillian A Scullion; Andrew Soulby; David A Kendall; Marie-Christine Pardon
    The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress.
    Behavioural brain research 2009;200(1):83-90.
  • 2009: K L Jones; D P Finn; R J M Governo; M J Prior; P G Morris; D A Kendall; C A Marsden; V Chapman
    Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain.
    Neuropharmacology 2009;56(2):405-13.
  • 2009: Stephen P H Alexander; David A Kendall
    The life cycle of the endocannabinoids: formation and inactivation.
    Current topics in behavioral neurosciences 2009;1():3-35.
  • 2009: Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
    Dynamic regulation of the endocannabinoid system: implications for analgesia.
    Molecular pain 2009;5():59.
  • 2009: Saoirse E O'Sullivan; David A Kendall; Michael D Randall
    Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma).
    PPAR research 2009;2009():425289.
  • 2008: Maulik D Jhaveri; Denise Richardson; Ian Robinson; Michael J Garle; Annie Patel; Yan Sun; Devi R Sagar; Andrew J Bennett; Stephen P H Alexander; David A Kendall; et al.
    Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Neuropharmacology 2008;55(1):85-93.
  • 2008: Jennifer L Brignell; Victoria Chapman; David A Kendall
    Comparison of icilin- and cold-evoked responses of spinal neurones, and their modulation of mechanical activity, in a model of neuropathic pain.
    Brain research 2008;1215():87-96.
  • 2008: M D Jhaveri; S J R Elmes; D Richardson; D A Barrett; D A Kendall; R Mason; V Chapman
    Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats.
    The European journal of neuroscience 2008;27(7):1722-30.
  • 2008: Denise Richardson; Richard G Pearson; Nisha Kurian; M Liaque Latif; Michael J Garle; David A Barrett; David A Kendall; Brigitte E Scammell; Alison J Reeve; Victoria Chapman
    Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
    Arthritis research & therapy 2008;10(2):R43.
  • 2007: Andriani Athanasiou; Anna B Clarke; Amy E Turner; Nethia M Kumaran; Sara Vakilpour; Paul A Smith; Dimitra Bagiokou; Tracey D Bradshaw; Andrew D Westwell; Lin Fang; et al.
    Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
    Biochemical and biophysical research communications 2007;364(1):131-7.
  • 2007: Y Sun; S P H Alexander; M J Garle; C L Gibson; K Hewitt; S P Murphy; D A Kendall; A J Bennett
    Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
    British journal of pharmacology 2007;152(5):734-43.
  • 2007: S P H Alexander; D A Kendall
    The complications of promiscuity: endocannabinoid action and metabolism.
    British journal of pharmacology 2007;152(5):602-23.
  • 2007: J D Wilkinson; D A Kendall; V Ralevic
    Delta 9-tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed.
    British journal of pharmacology 2007;152(5):709-16.
  • 2007: Paul A De Bank; Qingpu Hou; Robert M Warner; Ian V Wood; Bahaa E Ali; Sheila Macneil; David A Kendall; Barrie Kellam; Kevin M Shakesheff; Lee D K Buttery
    Accelerated formation of multicellular 3-D structures by cell-to-cell cross-linking.
    Biotechnology and bioengineering 2007;97(6):1617-25.
  • 2007: Maulik D Jhaveri; Devi R Sagar; Steven J R Elmes; David A Kendall; Victoria Chapman
    Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain.
    Molecular neurobiology 2007;36(1):26-35.
  • 2007: W Abdel-Razaq; T E Bates; D A Kendall
    The effects of antidepressants on cyclic AMP-response element-driven gene transcription in a model cell system.
    Biochemical pharmacology 2007;73(12):1995-2003.
  • 2007: Andriani Athanasiou; Paul A Smith; Sara Vakilpour; Nethia M Kumaran; Amy E Turner; Dimitra Bagiokou; Robert Layfield; David E Ray; Andrew D Westwell; Stephen P H Alexander; et al.
    Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.
    Biochemical and biophysical research communications 2007;354(1):50-5.
  • 2007: Michael D Randall; David A Kendall; Andrew J Bennett; Saoirse E O'Sullivan
    Rimonabant in obese patients with type 2 diabetes.
    Lancet 2007;369(9561):555.
  • 2007: Denise Richardson; Catharine A Ortori; Victoria Chapman; David A Kendall; David A Barrett
    Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.
    Analytical biochemistry 2007;360(2):216-26.
  • 2006: Maulik D Jhaveri; Denise Richardson; David A Kendall; David A Barrett; Victoria Chapman
    Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(51):13318-27.
  • 2006: P J Millns; M Chimenti; N Ali; E Ryland; E de Lago; J Fernandez-Ruiz; V Chapman; D A Kendall
    Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
    The European journal of neuroscience 2006;24(12):3489-95.
  • 2006: Y Sun; S P H Alexander; D A Kendall; A J Bennett
    Cannabinoids and PPARalpha signalling.
    Biochemical Society transactions 2006;34(Pt 6):1095-7.
  • 2006: Saoirse E O'Sullivan; David A Kendall; Michael D Randall
    Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol.
    The Journal of pharmacology and experimental therapeutics 2006;317(1):428-38.
  • 2006: D P Finn; M D Jhaveri; S R G Beckett; A Madjd; D A Kendall; C A Marsden; V Chapman
    Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats.
    Neuroscience 2006;138(4):1309-17.
  • 2005: Steven J R Elmes; Lisa A Winyard; Stephen J Medhurst; Nick M Clayton; Alex W Wilson; David A Kendall; Victoria Chapman
    Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
    Pain 2005;118(3):327-35.
  • 2005: Saoirse E O'Sullivan; Elizabeth J Tarling; Andrew J Bennett; David A Kendall; Michael D Randall
    Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma.
    Biochemical and biophysical research communications 2005;337(3):824-31.
  • 2005: David A Kendall; Stephen P H Alexander
    Assay of receptor-stimulated phosphoinositide turnover.
    Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.] 2005;Chapter 2():Unit2.7.
  • 2005: J K Richards; W Abdel-Razaq; T E Bates; D A Kendall
    The effects of desmethylimipramine on cyclic AMP-stimulated gene transcription in a model cell system.
    Biochemical pharmacology 2005;70(5):762-9.
  • 2005: Andrew S Yates; Stephen W Doughty; David A Kendall; Barrie Kellam
    Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor.
    Bioorganic & medicinal chemistry letters 2005;15(16):3758-62.
  • 2005: Devi Rani Sagar; Sara Kelly; Paul J Millns; Celestine T O'Shaughnessey; David A Kendall; Victoria Chapman
    Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    The European journal of neuroscience 2005;22(2):371-9.
  • 2005: Maulik D Jhaveri; Steven J R Elmes; David A Kendall; Victoria Chapman
    Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.
    The European journal of neuroscience 2005;22(2):361-70.
  • 2005: William P D Goldring; Stephen P H Alexander; David A Kendall; Gerald Pattenden
    Novel phomactin analogues as PAF receptor ligands.
    Bioorganic & medicinal chemistry letters 2005;15(13):3263-6.
  • 2005: Saoirse E O'Sullivan; David A Kendall; Michael D Randall
    The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    British journal of pharmacology 2005;145(4):514-26.
  • 2005: Paul A De Bank; David A Kendall; Stephen P H Alexander
    A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening.
    Biochemical pharmacology 2005;69(8):1187-93.
  • 2005: Saoirse E O'Sullivan; David A Kendall; Michael D Randall
    Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    European journal of pharmacology 2005;507(1-3):211-21.
  • 2005: M C Pardon; R E Roberts; C A Marsden; M Bianchi; M L Latif; M S Duxon; D A Kendall
    Social threat and novel cage stress-induced sustained extracellular-regulated kinase1/2 (ERK1/2) phosphorylation but differential modulation of brain-derived neurotrophic factor (BDNF) expression in the hippocampus of NMRI mice.
    Neuroscience 2005;132(3):561-74.
  • 2004: Steven J R Elmes; Maulik D Jhaveri; Darren Smart; David A Kendall; Victoria Chapman
    Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
    The European journal of neuroscience 2004;20(9):2311-20.
  • 2004: Steven J R Elmes; Paul J Millns; Darren Smart; David A Kendall; Victoria Chapman
    Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons.
    Brain research 2004;1022(1-2):205-13.
  • 2004: Marnie Duncan; David A Kendall; Vera Ralevic
    Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
    The Journal of pharmacology and experimental therapeutics 2004;311(1):411-9.
  • 2004: Marie-Christine Pardon; David A Kendall; Fernando Pérez-Diaz; Mark S Duxon; Charles A Marsden
    Repeated sensory contact with aggressive mice rapidly leads to an anticipatory increase in core body temperature and physical activity that precedes the onset of aversive responding.
    The European journal of neuroscience 2004;20(4):1033-50.
  • 2004: D P Finn; S R G Beckett; D Richardson; D A Kendall; C A Marsden; V Chapman
    Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors.
    The European journal of neuroscience 2004;20(3):848-52.
  • 2004: Devi R Sagar; Paul A Smith; Paul J Millns; Darren Smart; David A Kendall; Victoria Chapman
    TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.
    The European journal of neuroscience 2004;20(1):175-84.
  • 2004: Marnie Duncan; Paul Millns; Darren Smart; James E Wright; David A Kendall; Vera Ralevic
    Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
    British journal of pharmacology 2004;142(3):509-18.
  • 2004: Saoirse E O'Sullivan; David A Kendall; Michael D Randall
    Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    British journal of pharmacology 2004;142(3):435-42.
  • 2004: Michael D Randall; David A Kendall; Saoirse O'Sullivan
    The complexities of the cardiovascular actions of cannabinoids.
    British journal of pharmacology 2004;142(1):20-6.
  • 2004: Saoirse E O'Sullivan; David A Kendall; Michael D Randall
    Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA).
    British journal of pharmacology 2004;141(5):803-12.
  • 2004: Darawan Pinthong; Piyada Songsermsakul; Piyanee Rattanachamnong; David A Kendall
    The effects of imidazoline agents on the aggregation of human platelets.
    The Journal of pharmacy and pharmacology 2004;56(2):213-20.
  • 2004: D P Finn; S R G Beckett; C H Roe; A Madjd; K C F Fone; D A Kendall; C A Marsden; V Chapman
    Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
    The European journal of neuroscience 2004;19(3):678-86.
  • 2004: David P Finn; Maulik D Jhaveri; Simon R G Beckett; David A Kendall; Charles A Marsden; Victoria Chapman
    Cannabinoids modulate ultrasound-induced aversive responses in rats.
    Psychopharmacology 2004;172(1):41-51.
  • 2004: James D Leggett; S Aspley; S R G Beckett; A M D'Antona; D A Kendall; D A Kendall
    Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
    British journal of pharmacology 2004;141(2):253-62.
  • 2003: D Pinthong; D A Kendall; V G Wilson
    Complex interaction of alpha(2)-adrenoceptor binding sites with bovine brain and lung extracts containing clonidine-displacing substance.
    Annals of the New York Academy of Sciences 2003;1009():216-21.
  • 2003: D Pinthong; D A Kendall; S J Maclennan; R M Eglen; V G Wilson
    No evidence for activation of alpha(2)-adrenoceptors by methanolic extracts of bovine brain and lung containing clonidine-displacing substance.
    Annals of the New York Academy of Sciences 2003;1009():201-15.
  • 2003: Sara Kelly; Maulik D Jhaveri; Devi R Sagar; David A Kendall; Victoria Chapman
    Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation.
    The European journal of neuroscience 2003;18(8):2239-43.
  • 2003: D P Finn; M D Jhaveri; S R G Beckett; C H Roe; D A Kendall; C A Marsden; V Chapman
    Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats.
    Neuropharmacology 2003;45(5):594-604.
  • 2003: D M Sokal; S J R Elmes; D A Kendall; V Chapman
    Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats.
    Neuropharmacology 2003;45(3):404-11.
  • 2003: Patcharin Tep-areenan; David A Kendall; Michael D Randall
    Mechanisms of vasorelaxation to 17beta-oestradiol in rat arteries.
    European journal of pharmacology 2003;476(1-2):139-49.
  • 2003: J F Cheer; D A Kendall; R Mason; C A Marsden
    Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum.
    Neuropharmacology 2003;44(5):633-41.
  • 2003: P A De Bank; B Kellam; D A Kendall; K M Shakesheff
    Surface engineering of living myoblasts via selective periodate oxidation.
    Biotechnology and bioengineering 2003;81(7):800-8.
  • 2003: Patcharin Tep-areenan; David A Kendall; Michael D Randall
    Mechanisms of vasorelaxation to testosterone in the rat aorta.
    European journal of pharmacology 2003;465(1-2):125-32.
  • 2002: Vera Ralevic; David A Kendall; Michael D Randall; Darren Smart
    Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.
    Life sciences 2002;71(22):2577-94.
  • 2002: Michael D Randall; David Harris; David A Kendall; Vera Ralevic
    Cardiovascular effects of cannabinoids.
    Pharmacology & therapeutics 2002;95(2):191-202.
  • 2002: Louise C Kenny; Philip N Baker; David A Kendall; Michael D Randall; William R Dunn
    The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women.
    British journal of pharmacology 2002;136(8):1085-8.
  • 2002: Louise C Kenny; Philip N Baker; David A Kendall; Michael D Randall; William R Dunn
    Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia.
    Clinical science (London, England : 1979) 2002;103(1):67-73.
  • 2002: Vera Ralevic; David A Kendall
    Cannabinoids inhibit pre- and postjunctionally sympathetic neurotransmission in rat mesenteric arteries.
    European journal of pharmacology 2002;444(3):171-81.
  • 2002: David Harris; Audrey I McCulloch; David A Kendall; Michael D Randall
    Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.
    The Journal of physiology 2002;539(Pt 3):893-902.
  • 2002: Patcharin Tep-areenan; David A Kendall; Michael D Randall
    Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels.
    British journal of pharmacology 2002;135(3):735-40.
  • 2001: V Ralevic; D A Kendall; J C Jerman; D N Middlemiss; D Smart
    Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    European journal of pharmacology 2001;424(3):211-9.
  • 2001: V Ralevic; D A Kendall
    Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
    European journal of pharmacology 2001;418(1-2):117-25.
  • 2001: V Ralevic; D A Kendall; J C Jerman; J B Davis; D N Middlemiss; D Smart
    Low pH modulation of recombinant vanilloid receptors and perivascular capsaicin-sensitive sensory neurotransmission.
    Autonomic neuroscience : basic & clinical 2001;88(1-2):36-44.
  • 2001: P J Millns; V Chapman; D A Kendall
    Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
    British journal of pharmacology 2001;132(5):969-71.
  • 2000: D Harris; P E Martin; W H Evans; D A Kendall; T M Griffith; M D Randall
    Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K(+)-relaxation.
    European journal of pharmacology 2000;402(1-2):119-28.
  • 2000: V Ralevic; D A Kendall; M D Randall; P M Zygmunt; P Movahed; E D Högestätt
    Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries.
    British journal of pharmacology 2000;130(7):1483-8.
  • 2000: J F Cheer; D A Kendall; C A Marsden
    Cannabinoid receptors and reward in the rat: a conditioned place preference study.
    Psychopharmacology 2000;151(1):25-30.
  • 2000: L J Drew; J Harris; P J Millns; D A Kendall; V Chapman
    Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
    The European journal of neuroscience 2000;12(6):2079-86.
  • 2000: J F Cheer; C A Marsden; D A Kendall; R Mason
    Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.
    Neuroscience 2000;99(4):661-7.
  • 1999: R E Roberts; D A Kendall; V G Wilson
    alpha(2)-adrenoceptor and NPY receptor-mediated contractions of porcine isolated blood vessels: evidence for involvement of the vascular endothelium.
    British journal of pharmacology 1999;128(8):1705-12.
  • 1999: R E Roberts; D A Kendall; V G Wilson
    A study of NPY-mediated contractions of the porcine isolated ear artery.
    British journal of pharmacology 1999;127(1):284-90.
  • 1999: D A Clemett; D A Kendall; M I Cockett; C A Marsden; K C Fone
    Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors.
    British journal of pharmacology 1999;127(1):236-42.
  • 1999: J F Cheer; A K Cadogan; C A Marsden; K C Fone; D A Kendall
    Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
    Neuropharmacology 1999;38(4):533-41.
  • 1999: R A Bundey; D A Kendall
    Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line.
    Neuropharmacology 1999;38(1):39-47.
  • 1999: D Harris; D A Kendall; M D Randall
    Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor.
    Naunyn-Schmiedeberg's archives of pharmacology 1999;359(1):48-52.
  • 1998: R E Roberts; A E Tomlinson; D A Kendall; V G Wilson
    Alpha2-adrenoceptor-mediated contractions of the porcine isolated ear artery: evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanism.
    British journal of pharmacology 1998;124(6):1107-14.
  • 1998: M D Randall; D A Kendall
    Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery.
    European journal of pharmacology 1998;346(1):51-3.
  • 1998: M D Randall; D A Kendall
    Endocannabinoids: a new class of vasoactive substances.
    Trends in pharmacological sciences 1998;19(2):55-8.
  • 1997: M D Randall; D A Kendall
    Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
    European journal of pharmacology 1997;335(2-3):205-9.
  • 1997: R E Roberts; C A Marsden; D A Kendall
    Studies of inositol phosphate export from neuronal tissue in vitro.
    Journal of neurochemistry 1997;69(3):1291-9.
  • 1997: A K Cadogan; S P Alexander; E A Boyd; D A Kendall
    Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Journal of neurochemistry 1997;69(3):1131-7.
  • 1997: M D Randall; A I McCulloch; D A Kendall
    Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery.
    European journal of pharmacology 1997;333(2-3):191-7.
  • 1997: K E Neil; F Hernández; D A Kendall; S P Alexander
    Heterogeneity of beta-adrenoceptors in guinea-pig brain: radioligand binding and cyclic nucleotide generation.
    Journal of neurochemistry 1997;68(6):2610-7.
  • 1997: R A Bundey; P A Iredale; D A Kendall
    Corticosteroid modulation of signal transduction in the CATH.a cell line.
    Journal of neurochemistry 1997;68(1):362-9.
  • 1996: M D Randall; S P Alexander; T Bennett; E A Boyd; J R Fry; S M Gardiner; P A Kemp; A I McCulloch; D A Kendall
    An endogenous cannabinoid as an endothelium-derived vasorelaxant.
    Biochemical and biophysical research communications 1996;229(1):114-20.
  • 1996: K E Neil; D A Kendall; S P Alexander
    Coupling of metabotropic glutamate receptors to phosphoinositide mobilisation and inhibition of cyclic AMP generation in the guinea-pig cerebellum.
    British journal of pharmacology 1996;118(2):311-6.
  • 1995: I K Wright; D A Kendall; V G Wilson
    Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.
    Naunyn-Schmiedeberg's archives of pharmacology 1995;352(2):113-20.
  • 1995: D Pinthong; J F Hussain; D A Kendall; V G Wilson
    Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    British journal of pharmacology 1995;115(4):689-95.
  • 1995: I K Wright; N A Blaylock; D A Kendall; V G Wilson
    The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    British journal of pharmacology 1995;114(3):678-88.
  • 1995: G Singh; J F Hussain; A MacKinnon; C M Brown; D A Kendall; V G Wilson
    Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung.
    Naunyn-Schmiedeberg's archives of pharmacology 1995;351(1):17-26.
  • 1995: D Pinthong; I K Wright; C Hanmer; P Millns; R Mason; D A Kendall; V G Wilson
    Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors.
    Naunyn-Schmiedeberg's archives of pharmacology 1995;351(1):10-6.
  • 1995: I K Wright; R Harling; D A Kendall; V G Wilson
    Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein.
    British journal of pharmacology 1995;114(1):157-65.
  • 1994: S P Alexander; A R Curtis; D A Kendall; S J Hill
    A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    British journal of pharmacology 1994;113(4):1501-7.
  • 1994: A J Fulford; S Butler; D J Heal; D A Kendall; C A Marsden
    Evidence for altered alpha 2-adrenoceptor function following isolation-rearing in the rat.
    Psychopharmacology 1994;116(2):183-90.
  • 1994: I K Wright; S Amirchetty-Rao; D A Kendall
    Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.
    British journal of pharmacology 1994;112(4):1146-50.
  • 1994: F Hernández; S P Alexander; D A Kendall
    Forskolin and 3-isobutyl-1-methylxanthine increase basal and sodium nitroprusside-elevated cyclic GMP levels in adult guinea-pig cerebellar slices.
    Journal of neurochemistry 1994;62(6):2212-8.
  • 1994: A K Cadogan; D A Kendall; C A Marsden
    Serotonin 5-HT1A receptor activation increases cyclic AMP formation in the rat hippocampus in vivo.
    Journal of neurochemistry 1994;62(5):1816-21.
  • 1994: J Cartmell; J A Kemp; S P Alexander; H Shinozaki; D A Kendall
    Modulation of cyclic AMP formation by putative metabotropic receptor agonists.
    British journal of pharmacology 1994;111(1):364-9.
  • 1994: S P Alexander; A Losinski; D A Kendall; S J Hill
    A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.
    British journal of pharmacology 1994;111(1):185-90.
  • 1993: F Hernández; D A Kendall; S P Alexander
    Adenosine receptor-induced second messenger production in adult guinea-pig cerebellum.
    British journal of pharmacology 1993;110(3):1085-90.
  • 1993: D A Kendall
    Direct and indirect responses to metabotropic glutamate receptor activation in the brain.
    Biochemical Society transactions 1993;21(4):1120-3.
  • 1993: J F Hussain; D A Kendall; V G Wilson
    Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    British journal of pharmacology 1993;109(3):831-7.
  • 1993: J Cartmell; A R Curtis; J A Kemp; D A Kendall; S P Alexander
    Subtypes of metabotropic excitatory amino acid receptor distinguished by stereoisomers of the rigid glutamate analogue, 1-aminocyclopentane-1,3-dicarboxylate.
    Neuroscience letters 1993;153(1):107-10.
  • 1993: A K Cadogan; C A Marsden; I Tulloch; D A Kendall
    Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.
    Neuropharmacology 1993;32(3):249-56.
  • 1993: P A Iredale; K F Martin; S J Hill; D A Kendall
    The effects of beta-phorbol-12,13 dibutyrate on agonist-induced increases in [Ca2+]i in N1E-115 cells. Differential modulation of responses to angiotensin II and bradykinin.
    Biochemical pharmacology 1993;45(3):611-7.
  • 1993: J Cartmell; J A Kemp; S P Alexander; D A Kendall
    Endogenous adenosine regulates the apparent efficacy of 1-aminocyclopentyl-1S,3R-dicarboxylate inhibition of forskolin-stimulated cyclic AMP accumulation in rat cerebral cortical slices.
    Journal of neurochemistry 1993;60(2):780-2.
  • 1993: P A Iredale; K F Martin; S J Hill; D A Kendall
    The control of intracellular calcium and neurotransmitter release in guinea pig-derived cerebral cortical synaptoneurosomes.
    Biochemical pharmacology 1993;45(2):407-14.
  • 1992: P A Iredale; K F Martin; S P Alexander; S J Hill; D A Kendall
    Inositol 1,4,5-trisphosphate generation and calcium mobilisation via activation of an atypical P2 receptor in the neuronal cell line, N1E-115.
    British journal of pharmacology 1992;107(4):1083-7.
  • 1992: S P Alexander; A R Curtis; S J Hill; D A Kendall
    Activation of a metabotropic excitatory amino acid receptor potentiates A2b adenosine receptor-stimulated cyclic AMP accumulation.
    Neuroscience letters 1992;146(2):231-3.
  • 1992: P A Iredale; K F Martin; S P Alexander; S J Hill; D A Kendall
    Qualitative differences in [Ca2+]i increases and InsP3 generation following stimulation of N1E-115 cells with micromolar and millimolar ATP.
    Biochemical pharmacology 1992;44(8):1479-87.
  • 1992: S P Alexander; D A Kendall; S J Hill
    Excitatory amino acid-induced phosphoinositide turnover in guinea pig cerebral cortical slices: selective enhancement by spermine of the response to DL-1-aminocyclopentane-trans-1,3-dicarboxylate.
    Journal of neurochemistry 1992;59(2):610-5.
  • 1992: P A Iredale; K F Martin; S J Hill; D A Kendall
    Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol.
    European journal of pharmacology 1992;226(2):163-8.
  • 1992: J Cartmell; J A Kemp; S P Alexander; S J Hill; D A Kendall
    Inhibition of forskolin-stimulated cyclic AMP formation by 1-aminocyclopentane-trans-1,3-dicarboxylate in guinea-pig cerebral cortical slices.
    Journal of neurochemistry 1992;58(5):1964-6.
  • 1992: S P Alexander; D A Kendall; S J Hill
    Spermine enhances calcium- and GTP analogue-stimulated particulate phosphoinositidase.
    Biochemical Society transactions 1992;20(1):20S.
  • 1992: D A Kendall
    Biochemical correlates of alpha 1-adrenoceptor activation.
    Biochemical Society transactions 1992;20(1):109-13.
  • 1991: S P Alexander; S J Hill; D A Kendall
    Do polyamines regulate the NMDA inhibition of muscarinic receptor-induced phosphoinositide turnover in guinea pig brain?
    Neuroscience letters 1991;131(2):167-70.
  • 1991: A Ruck; D A Kendall; S J Hill
    Alpha- and beta-adrenoceptor regulation of cyclic AMP accumulation in cultured rat astrocytes. A comparison of primary protoplasmic and mixed fibrous/protoplasmic astroglial cultures.
    Biochemical pharmacology 1991;42(1):59-69.
  • 1991: P A Iredale; A Ruck; K F Martin; D A Kendall; S J Hill
    Histamine-induced changes in intracellular calcium in undifferentiated N1E-115 cells.
    Biochemical Society transactions 1991;19(1):6S.
  • 1990: D A Kendall; J P Robinson
    The glycine antagonist 7-chlorokynurenic acid blocks the effects of N-methyl-D-aspartate on agonist-stimulated phosphoinositide hydrolysis in guinea-pig brain slices.
    Journal of neurochemistry 1990;55(6):1915-9.
  • 1990: A Ruck; P Millns; D A Kendall; S J Hill
    Expression of beta 2-adrenoceptors mediating cyclic AMP accumulation in astroglial and neuronal cell lines derived from the rat CNS.
    Biochemical pharmacology 1990;40(10):2371-5.
  • 1990: S P Alexander; S J Hill; D A Kendall
    Differential effects of elevated calcium ion concentrations on inositol phospholipid responses in mouse and rat cerebral cortical slices.
    Biochemical pharmacology 1990;40(8):1793-9.
  • 1990: S P Alexander; S J Hill; D A Kendall
    Is the adenosine receptor modulation of histamine-induced accumulation of inositol phosphates in cerebral cortical slices mediated by effects on calcium ion fluxes?
    Journal of neurochemistry 1990;55(4):1138-41.
  • 1990: S P Alexander; S J Hill; D A Kendall
    Excitatory amino acid-induced formation of inositol phosphates in guinea-pig cerebral cortical slices: involvement of ionotropic or metabotropic receptors?
    Journal of neurochemistry 1990;55(4):1439-41.
  • 1990: P Whitworth; D J Heal; D A Kendall
    The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo.
    British journal of pharmacology 1990;101(1):39-44.
  • 1990: D A Kendall; P Whitworth
    Lithium amplifies inhibitions of inositol phospholipid hydrolysis in mammalian brain slices.
    British journal of pharmacology 1990;100(4):723-8.
  • 1990: J P Robinson; D A Kendall
    Niguldipine discriminates between alpha 1-adrenoceptor-mediated second messenger responses in rat cerebral cortex slices.
    British journal of pharmacology 1990;100(1):3-4.
  • 1990: J Donaldson; D A Kendall; S J Hill
    Discriminatory effects of forskolin and EGTA on the indirect cyclic AMP responses to histamine, noradrenaline, 5-hydroxytryptamine, and glutamate in guinea-pig cerebral cortical slices.
    Journal of neurochemistry 1990;54(5):1484-91.
  • 1989: P Whitworth; D J Heal; D A Kendall
    Chronic lithium treatment enhances inositol polyphosphate formation in mouse brain in vivo.
    British journal of pharmacology 1989;98 Suppl():834P.
  • 1989: S P Alexander; S J Hill; D A Kendall
    The 2-chloroadenosine inhibition of histamine-induced inositol phosphates accumulation in mouse brain and calcium ions.
    British journal of pharmacology 1989;98 Suppl():832P.
  • 1989: J P Robinson; D A Kendall
    No role for phospholipase A2 and protein kinase C in the potentiation by alpha-adrenoceptors of beta-adrenoceptor-mediated cyclic AMP formation in rat brain.
    Journal of neurochemistry 1989;53(2):542-50.
  • 1989: P Whitworth; D A Kendall
    Effects of lithium on inositol phospholipid hydrolysis and inhibition of dopamine D1 receptor-mediated cyclic AMP formation by carbachol in rat brain slices.
    Journal of neurochemistry 1989;53(2):536-41.
  • 1989: J P Robinson; D A Kendall
    Inositol phospholipid hydrolysis and potentiation of cyclic AMP formation by noradrenaline in rat cerebral cortex slices are not mediated by the same alpha-adrenoceptor subtypes.
    Journal of neurochemistry 1989;52(3):690-8.
  • 1989: S J Hill; D A Kendall
    Cross-talk between different receptor-effector systems in the mammalian CNS.
    Cellular signalling 1989;1(2):135-41.
  • 1988: D A Kendall; S J Hill
    Adenosine inhibition of histamine-stimulated inositol phospholipid hydrolysis in mouse cerebral cortex.
    Journal of neurochemistry 1988;50(2):497-502.
Register to see more